Später, T.; Kaneda, G.; Chavez, M.; Sheyn, J.; Wechsler, J.; Yu, V.; Del Rio, P.; Huang, D.; Metzger, M.; Tawackoli, W.;
et al. Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites. Bioengineering 2023, 10, 1049.
https://doi.org/10.3390/bioengineering10091049
AMA Style
Später T, Kaneda G, Chavez M, Sheyn J, Wechsler J, Yu V, Del Rio P, Huang D, Metzger M, Tawackoli W,
et al. Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites. Bioengineering. 2023; 10(9):1049.
https://doi.org/10.3390/bioengineering10091049
Chicago/Turabian Style
Später, Thomas, Giselle Kaneda, Melissa Chavez, Julia Sheyn, Jacob Wechsler, Victoria Yu, Patricia Del Rio, Dave Huang, Melodie Metzger, Wafa Tawackoli,
and et al. 2023. "Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites" Bioengineering 10, no. 9: 1049.
https://doi.org/10.3390/bioengineering10091049
APA Style
Später, T., Kaneda, G., Chavez, M., Sheyn, J., Wechsler, J., Yu, V., Del Rio, P., Huang, D., Metzger, M., Tawackoli, W., & Sheyn, D.
(2023). Retention of Human iPSC-Derived or Primary Cells Following Xenotransplantation into Rat Immune-Privileged Sites. Bioengineering, 10(9), 1049.
https://doi.org/10.3390/bioengineering10091049
